Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single-Cell Sequence Technology Used to Reveal Heterogeneity of Secondary Hyperparathyroidism

NCT06130683 is registered in ClinicalTrials.gov with China-Japan Friendship Hospital as lead sponsor.

NCT NCT06130683
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06130683 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single-Cell Sequence Technology Used to Reveal Heterogeneity of Secondary Hyperparathyroidism
Lead sponsor
China-Japan Friendship Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
November 10, 2023
Completion date
July 31, 2025
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

secondary hyperparathyroidism